The weekend is almost here! From St. Patrick’s Day events to Purim Carnivals to the Saratoga Reptile Show, there are quite a few things to do on March 14, 15, and 16.

Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio ...

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

After high-stakes ceasefire talks with the U.S., Ukrainian President Volodymyr Zelensky has made his first big statement, ...

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.

The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly ...

We recently compiled a list of the 15 Best EV Stocks To Buy According to Billionaires. In this article, we are going to take ...

There are a limited number of accessible parking bays available for £15 per space. To book please call Preston North End ...

Hezbollah’s new leader, Naim Qassem, has spoken out for the first time since taking over after Hassan Nasrallah’s ...

The Arizona bus envelops you in warmth and calmness with its organic design that blends natural materials, handcrafted ...